CALT Stock Performance and Key Statistics

CALT has a current P/E ratio of -21.05

The CALT stock has a trailing twelve month price-to sales (P/S) ratio of 16.26 while its price-to-book (P/B) value is 29.31.

CALT's price-to-free-cashflow (P/FCF) ratio is -43.87, an indicator that is currently being trending upward.

Based on CALT's recent bid, its distance from 20 days simple moving average is -0.76%. It is 1.28% apart from 50 days simple moving average, and it is 39.49% apart from 200 days simple moving average.

The 52-week high for CALT is $43.00 which is -6.98% away from the current price level whereas the distance of that from the 52-week low of $15.25 stands at 162.3%.

The performance of CALT stock was not encouraging with most of its significant price indicators in green. Calliditas Therapeutics AB (publ)(NASDAQ: CALT) shares have moved downward -0.10% or - $0.04 in the latest trading session and have gained 55.38% year-to-date (YTD). The stock has gained nearly 146.91% over the past year. After moving 3.28% over the trailing 3-month period, the stock is 87.79% higher in the 6-month period. Looking at its performance over the shorter term, it'slost 0% a week and -1.33% a month.

The current 14-day RSI for CALT stock is 50.49. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Calliditas Therapeutics AB (publ) (CALT) has a 14-day ATR of 1.05.

After closing at $40.04 with 53.69M of its shares outstanding, the current enterprise value of CALT is roughly 5.39B.

Calliditas Therapeutics AB (publ) (NASDAQ: CALT) is up 146.91% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 11.81%. CALT stock price is also up 55.38% on its value in year-to-date trading.

The number outstanding shares of CALT is 53.69M, and of these 2.5% shares are freely available for trading. On average, CALT stock has traded - shares per day for the past 10 days. A total of 9.8K shares changed hands during the last trading session with the average session volume of 7.73K shares.